CNS – Dividend Returns, History & Calculator

Dividend Contender 16 Years

Cohen & Steers, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides its services to institutional investors, including pension funds, endowments, and foundations. It manages separate client-focused equity, fix

...

Company Info

Symbol CNS
Company Cohen & Steers Inc
Sector Financial Services
Industry Asset Management
Website Visit
Market Cap $3,393.8M

Price Data

Price $66.55
Price Change -0.49
Price Change % -0.73%
Next Earnings Oct 16, 2025
Low (52W) $64.29
High (52W) $110.67

Dividend Data

Div Yield 372.65%
5Y Avg Yield 338.42%
Current Div $0.620
Payouts/Year 4
Annualized $2.480
Previous Div $0.620
Ex-Date Aug 11, 2025

Growth Rates

Chowder Number -3.3
DGR 1Y 4.7%
DGR 3Y -9.9%
DGR 5Y -7.0%
DGR 10Y 2.2%

Total Returns

TTR 1Y - With Specials -29.8%
TTR 3Y - With Specials 11.2%
TTR 1Y - No Specials -29.8%
TTR 3Y - No Specials 11.2%

Fair Value

Fair Value (P/E 10) $60.05
FV (P/E 10) % 11.0%
Fair Value (Peter Lynch) $15.75
FV (Peter Lynch) % 323.0%
Fair Value (Blended) $62.75
FV (Blended) % 6.0%

Financial Metrics

Revenue 1Y 5.7%
NPM 29.8%
CF/Share $-2.28
ROE 32.6%
Current R 5.5x
Debt/Capital 21.0%
ROTC 24.9%
P/E 21.1x
P/BV 6.4x
PEG 1.71
📊 Financial data last updated: October 16, 2025 9:56 am

Calculate your CNS Dividend Returns

Quickly and easily calculate CNS dividend yield using our CNS calculator. Adjust the fields below to see how your CNS investments snowball over time.

Show Idealized Scenario (Assumes all future extra investments and dividends are made on Day 1 and reinvested instantly — this creates a best-case scenario for compounding growth.)

Portfolio Growth Over Time

Data last updated: October 17, 2025 1:42 am

Year-by-Year Portfolio Growth (Realistic DRIP Scenario)

YearStart BalanceStart SharesShare PriceDividend / ShareDividend YieldYield on CostAnnual DividendTotal DividendsEnd SharesEnd Balance
1$10,000152$65.80$0.623.77%3.77%$411$411176$11,611
2$12,624176$71.54$0.613.40%3.70%$461$871200$14,285
3$15,532200$77.79$0.603.07%3.63%$505$1,377222$17,238
4$18,742222$84.58$0.592.77%3.56%$545$1,922242$20,488
5$22,276242$91.97$0.572.50%3.49%$581$2,503262$24,057
6$26,157262$99.99$0.562.25%3.43%$612$3,115280$27,969
7$30,411280$108.72$0.552.03%3.36%$639$3,754297$32,250
8$35,065297$118.22$0.541.84%3.30%$662$4,416312$36,928
9$40,151312$128.54$0.531.66%3.24%$682$5,098327$42,033
10$45,703327$139.76$0.521.50%3.18%$698$5,796341$47,601

CNS Dividend History

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
08/11/202508/11/2025$0.6203.34%3.38%$73.35
05/12/202505/12/2025$0.6202.92%2.99%$82.87
03/03/202503/03/2025$0.6202.79%2.90%$85.60
11/18/202411/18/2024$0.5902.36%2.36%$99.89
08/12/202408/12/2024$0.5902.85%2.88%$82.02
05/10/202405/10/2024$0.5903.28%3.34%$70.72
03/01/202403/01/2024$0.5903.15%3.23%$73.05
11/10/202311/10/2023$0.5704.32%4.32%$52.82
08/11/202308/11/2023$0.5703.43%3.46%$65.98
05/12/202305/12/2023$0.5704.13%4.20%$54.30
03/03/202303/03/2023$0.5703.10%3.18%$71.69
11/10/202211/10/2022$0.5503.41%3.41%$64.45
08/12/202208/12/2022$0.5504.31%2.83%$77.66
05/13/202205/13/2022$0.5504.46%3.02%$72.87
03/04/202203/04/2022$0.5504.04%2.82%$78.01
11/12/202111/12/2021$1.703.06%6.82%$99.75
08/13/202108/13/2021$0.4503.11%2.04%$88.17
05/14/202105/14/2021$0.4503.67%2.46%$73.08
03/05/202103/05/2021$0.4503.98%2.73%$65.89
11/13/202011/13/2020$1.394.02%8.74%$63.61
Page 1 of 1

CNS 10-yr Total Return ($10,000 invested)

This analysis of CNS demonstrates the power of dividend reinvestment over a 10-year period with a $10,000 initial investment. The dividend reinvestment strategy delivered a 14.7% CAGR, representing strong long-term performance. While recent 5-year returns averaged 7.3% annually, the exceptional 10-year performance of 14.7% demonstrates sustained long-term growth. Dividend payments have grown from $0.6200 to $0.7500 per share, reflecting the 9.5% annual dividend growth rate. The DRIP strategy provided 19% more total return compared to collecting dividends as cash, highlighting the compounding effect of reinvestment.

With DRIP No DRIP

Total Return with and without DRIP (CNS)

Over the selected period, investing $10,000 in CNS would grow to $67,282 with DRIP (572.8%), and $50,397 without DRIP (404.0%).

CNS Dividend Reinvestment Snowball

Investing $10,000 + $100/mo in CNS with historic price growth (8.75%) and dividend growth (-1.89%) produces dramatically different outcomes depending on whether you reinvest dividends.

After 20 Years

Your Investment: $34,000

With DRIP

Portfolio: $146,949

Annual Dividend: $705

Yield on Cost: 2.07%

Total Dividends: $12,815

No DRIP

Portfolio: $126,885

Total Dividends: $10,810

After 30 Years

Your Investment: $46,000

With DRIP

Portfolio: $369,636

Annual Dividend: $634

Yield on Cost: 1.38%

Total Dividends: $19,613

No DRIP

Portfolio: $303,630

Total Dividends: $16,134

Milestones on the way

By year 13, the compounding really starts to show. Your total dividends collected reach $7,789 against a total investment of $25,600. At this point, your portfolio is throwing off $705 per year in dividends alone.

By year 17, the annual dividend climbs to around your initial contribution. For a starting investment of $10,000, the yearly dividend now sits at approximately $713, a powerful “income on autopilot” milestone.

After two decades, cumulative dividends total $12,815 versus $34,000 invested, nearly a 38% recovery of capital purely from income. Yield on cost reaches 2.07%.

At year 25, the income engine takes over. The portfolio’s annual dividend of $675 is greater than total contributions to date ($40,000), and cumulative dividends exceed $16,307.

By year 30, the DRIP snowball is in full force. Yearly income reaches $634, cumulative dividends total $19,613, and the DRIP portfolio value stands at $369,636, compared with $303,630 if dividends weren’t reinvested.

How we estimate these numbers

We use the latest calculator inputs for CNS, price $65.94, dividend per period $0.62 (4×/year), along with historic growth assumptions: price growth 8.75% and dividend growth -1.89% annually.

We simulate month by month for 30 years. Every month, a $100 contribution is added and converted to shares at that month’s price. Dividends are paid roughly evenly across the year based on the dividend frequency; in the DRIP path, each payout immediately buys additional shares at the then-current price. In the No‑DRIP path, dividends accrue as cash. Prices grow using a monthly rate derived from the annual price growth. Dividends per share increase once per year at the annual dividend growth rate.

This model isn’t investment advice; it’s a simple, transparent framework that illustrates how reinvesting dividends can accelerate both income and total return over time.

Projected Future Returns & Dividends for CNS

Based on past 10-year performance, here are CNS growth metrics:

Share price CAGR of +9.63%
Dividend CAGR of +2.20%

Using CNS CAGR metrics, we can estimate that your initial $10,000 investment, over the next 10 years, should grow as follows:

CNS (DRIP)CNS (No DRIP)
Current Price$65.94$65.94
Start Shares151.65151.65
Start Value$10,000$10,000
After 10 years:
Final Share Count196.20151.65
Dividends Payment$3.08$3.08
Annual Dividends$594$468
Yield on cost5.94%4.68%
Share Price$165.29$165.29
Total Dividends$4,878$4,249
Final Value$32,429$29,315

Estimated Future Value + Dividends – CNS

Dividend History: Payments & Yield

Shows quarterly dividend payments with trailing yield and a 5-year rolling average overlay. Use the range pills to switch the visible period.

Yield Dividend

Dividend Growth

Lifetime quarterly dividend amounts, with range controls for 1Y/2Y/5Y/10Y. Useful to visualize the cadence and pace of dividend increases over time.

Dividend

Dividend Payments & Yield

Quarterly dividends with TTM yield and a 5‑year rolling average overlay. Helps compare current yield versus recent history across different ranges.

Dividend 5-yr Rolling AVG Yield

CNS Dividend History

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
08/11/202508/11/2025$0.6203.34%3.38%$73.35
05/12/202505/12/2025$0.6202.92%2.99%$82.87
03/03/202503/03/2025$0.6202.79%2.90%$85.60
11/18/202411/18/2024$0.5902.36%2.36%$99.89
08/12/202408/12/2024$0.5902.85%2.88%$82.02
05/10/202405/10/2024$0.5903.28%3.34%$70.72
03/01/202403/01/2024$0.5903.15%3.23%$73.05
11/10/202311/10/2023$0.5704.32%4.32%$52.82
08/11/202308/11/2023$0.5703.43%3.46%$65.98
05/12/202305/12/2023$0.5704.13%4.20%$54.30
03/03/202303/03/2023$0.5703.10%3.18%$71.69
11/10/202211/10/2022$0.5503.41%3.41%$64.45
08/12/202208/12/2022$0.5504.31%2.83%$77.66
05/13/202205/13/2022$0.5504.46%3.02%$72.87
03/04/202203/04/2022$0.5504.04%2.82%$78.01
11/12/202111/12/2021$1.703.06%6.82%$99.75
08/13/202108/13/2021$0.4503.11%2.04%$88.17
05/14/202105/14/2021$0.4503.67%2.46%$73.08
03/05/202103/05/2021$0.4503.98%2.73%$65.89
11/13/202011/13/2020$1.394.02%8.74%$63.61
08/14/202008/14/2020$0.3905.71%2.52%$61.87
05/15/202005/15/2020$0.3905.88%2.62%$59.50
02/28/202002/28/2020$0.3905.54%2.49%$62.65
11/15/201911/15/2019$2.365.25%14.41%$65.49
08/09/201908/09/2019$0.3607.38%2.72%$52.96
05/10/201905/10/2019$0.3607.66%2.84%$50.63
03/01/201903/01/2019$0.3609.19%3.44%$41.88
11/16/201811/16/2018$2.8310.66%31.58%$35.84
08/15/201808/15/2018$0.3305.43%3.16%$41.78
05/30/201805/30/2018$0.3305.64%3.35%$39.38
03/07/201803/07/2018$0.3305.26%3.20%$41.27
11/21/201711/21/2017$1.284.74%11.45%$44.73
08/30/201708/30/2017$0.2804.28%2.99%$37.41
05/30/201705/30/2017$0.2804.05%2.87%$39.00
03/07/201703/07/2017$0.2804.16%2.99%$37.51
11/21/201611/21/2016$0.7604.40%8.68%$35.04
08/30/201608/30/2016$0.2603.59%2.44%$42.59
05/31/201605/31/2016$0.2603.94%2.70%$38.59
03/07/201603/07/2016$0.2604.47%3.08%$33.80
11/23/201511/23/2015$0.7504.85%9.69%$30.96
09/01/201509/01/2015$0.2506.99%3.55%$28.19
05/29/201505/29/2015$0.2505.17%2.67%$37.50
03/11/201503/11/2015$0.2504.69%2.45%$40.75
11/25/201411/25/2014$1.224.31%11.17%$43.67
09/03/201409/03/2014$0.2204.24%2.01%$43.89
05/30/201405/30/2014$0.2204.54%2.17%$40.49
03/26/201403/26/2014$0.2204.57%2.21%$39.82
11/27/201311/27/2013$1.204.50%12.01%$39.96
09/04/201309/04/2013$0.2007.07%2.48%$32.26
05/30/201305/30/2013$0.2005.83%2.06%$38.75
03/25/201303/25/2013$0.2006.42%2.29%$34.87
11/28/201211/28/2012$1.687.82%23.66%$28.40
09/05/201209/05/2012$0.1802.05%2.14%$33.63
05/31/201205/31/2012$0.1805.13%2.23%$32.35
03/27/201203/27/2012$0.1805.25%2.32%$31.06
12/05/201112/05/2011$0.1505.58%2.09%$28.68
09/02/201109/02/2011$1.154.47%13.26%$34.70
06/01/201106/01/2011$0.1508.58%2.06%$29.14
03/29/201103/29/2011$0.1508.49%2.08%$28.87
12/02/201012/02/2010$0.1008.91%1.48%$26.94
09/02/201009/02/2010$2.1011.70%41.83%$20.08
06/02/201006/02/2010$0.1001.27%1.70%$23.54
03/29/201003/29/2010$0.1001.00%1.60%$24.97
12/02/200912/02/2009$0.0501.04%1.04%$19.23
09/02/200909/02/2009$0.0501.32%1.05%$19.01
06/02/200906/02/2009$0.0502.52%1.20%$16.70
03/27/200903/27/2009$0.0504.86%1.65%$12.13
12/03/200812/03/2008$0.1005.88%3.10%$12.92
09/03/200809/03/2008$0.2202.94%3.01%$29.21
06/02/200806/02/2008$0.2202.83%2.89%$30.44
03/07/200803/07/2008$0.2203.49%3.65%$24.10
12/03/200712/03/2007$0.2002.89%2.81%$28.44
11/20/200711/20/2007$0.2222.87%3.10%$28.60
08/31/200708/31/2007$0.2002.20%2.41%$33.23
05/31/200705/31/2007$0.2001.27%1.54%$51.99
03/30/200703/30/2007$0.2001.32%1.86%$43.08
12/29/200612/29/2006$0.1301.19%1.29%$40.17
09/28/200609/28/2006$0.1301.44%1.62%$32.01
06/27/200606/27/2006$0.1101.88%1.92%$22.87
03/27/200603/27/2006$0.1101.82%1.82%$24.22
12/27/200512/27/2005$0.1102.43%2.38%$18.51
10/12/200510/12/2005$0.1002.34%2.12%$18.84
06/13/200506/13/2005$0.1202.35%2.56%$18.74
05/11/200505/11/2005$0.1202.49%2.85%$16.85
03/24/200503/24/2005$0.1001.88%2.50%$15.97
12/27/200412/27/2004$0.1001.31%2.63%$15.22
09/23/200409/23/2004$0.1000.63%2.51%$15.92
Page 1 of 1

Dividend Payout Ratio

Tracks the percentage of earnings paid out as dividends each quarter. Lower and stable ratios often indicate safer, more sustainable payouts.

Payout Ratio

Dividend to Free Cash Flow Ratio

Shows dividends as a percentage of free cash flow. Consistently high values may signal limited reinvestment capacity or potential dividend risk.

Dividend/FCF Ratio

Share Price

Historical closing price with range controls. Table view includes quarter‑over‑quarter and year‑over‑year changes for additional context.

CNS Price

Price to Earnings

CNS trades at a 90.3x price-to-earnings ratio. This elevated valuation suggests investors expect strong future growth.

Price to Sales

CNS trades at a 26.6x price-to-sales ratio, providing insight into market valuation relative to revenue generation.

Revenue

CNS generated $0.1B in revenue.

Net Income

CNS reported $0.0B in net income. Net income has declined by 21% over the period.

Revenue vs Net Income

CNS generated $0.1B in revenue with net income of $0.0B, representing a 29.4% net profit margin.

Gross Profit

CNS achieved $0.1B in gross profit, showing revenue after direct production costs.

Operating Income

CNS generated $0.0B in operating income, representing profit from core business operations.

EBITDA

CNS generated $0.1B in EBITDA, measuring operational profitability before interest, taxes, depreciation, and amortization.

Operating Cash Flow

CNS generated $0.0B in operating cash flow, demonstrating the company’s ability to convert earnings into cash.

Free Cash Flow

CNS generated $0.0B in free cash flow. Free cash flow has decreased by 23% over the period.

Free Cash Flow / Share

CNS generates $0.84 in free cash flow per share. FCF per share has declined by 23% over the period.

Earnings Per Share (EPS)

CNS reported $0.82 in earnings per share. EPS has declined by 21% over the period.

Return on Equity (ROE)

CNS delivered a 24.5% return on equity, indicating how effectively the company generates returns for shareholders.

Return on Assets (ROA)

CNS achieved a 14.7% return on assets, measuring how efficiently the company uses its assets to generate profit.

Net Profit Margin

CNS maintains a 29.4% net profit margin, showing the percentage of revenue retained as profit after all expenses.

Gross Profit Margin

CNS operates with a 76.7% gross profit margin, reflecting pricing power and cost efficiency in core operations.

Cash & Debt

CNS holds $0.0B in cash against $0.0B in debt, resulting in a net cash position of $0.0B.

Shares Outstanding

CNS has 0.1B shares outstanding.

Stock-Based Comp

CNS reported $0.0B in stock-based compensation.

FCF vs Stock Based Comp

CNS generated $0.0B in free cash flow while spending $0.0B on stock-based compensation, representing 8% of FCF.

FCF vs FCF / Share

CNS reported $0.0B in free cash flow, translating to $0.84 per share.

Revenue: Actual + Estimates

This chart tracks CNS revenue: actual + estimates metrics over time, providing insights into the company’s financial performance and trends.

EPS: Actual + Estimates

This chart tracks CNS eps: actual + estimates metrics over time, providing insights into the company’s financial performance and trends.

Net Income: Actual + Estimates

This chart tracks CNS net income: actual + estimates metrics over time, providing insights into the company’s financial performance and trends.

EBITDA: Actual + Estimates

This chart tracks CNS ebitda: actual + estimates metrics over time, providing insights into the company’s financial performance and trends.

Disclaimer: The information on this page is for educational and entertainment purposes only and does not constitute financial advice. Do your own research and consult a qualified financial advisor before making investment decisions. Data sources include Yahoo Finance and other third-party providers and may contain errors or delays.

Download now

Get your dividend champions spreadsheet.